Top news
Full FDA approval of Pfizer vaccine opens door for vaccine mandates in Texas
By Joshua Fechter & Patrick Svitek
Fact check: Some, but not all, of FDA's funding comes from the companies whose products it approves
By Miriam Fauzia
Covid infection protection waning in double jabbed
By Michelle Roberts
All coverage
Get Shots or Get Out, U.S. Employers Are Telling Workers
By Kara Wetzel, Jonathan Levin, CFA & Skylar Woodhouse
Myocarditis More Common After Covid Vaccination, Study Finds
By Emily Anthes & Noah Mercer Weiland
FDA Delays Carry a Death Toll
By Conor Friedersdorf
Under-12s are increasingly catching COVID-19. How sick are they getting and when will we be able to vaccinate them?
By Nicholas Wood
U.S. plans COVID-19 booster shots at six months instead of eight - WSJ
By Arun Koyyur & Manojna Maddipatla
Pfizer's full FDA approval could lead to even greater profits
By Tara Suter & Melissa Holzberg Depalo
You asked, we answered: Are Pfizer's Comirnaty and BioNTech COVID-19 vaccines the same or different?
Vaccine hesitancy unlikely to disappear because of FDA approval
By Phil McCausland & Erik Ortiz
Heart inflammation risk boosted slightly by vaccine, more by COVID-19 -study
By Manojna Maddipatla
J&J Says A Booster Shot For Its Vaccine May Have Big Benefits
By Joe Hernandez
Extra Shots from J. & J. and Pfizer Give Immune Boost, Companies Report (Published 2021)
By Sharon LaFraniere & Carl Zimmer
F.D.A. Fully Approves Pfizer Vaccine
By Sharon LaFraniere & Noah Mercer Weiland
Do I need a booster shot if I got the Johnson & Johnson vaccine? A virologist answers 5 questions
By Maureen Ferran